ROCHE HOLDING LTD's Net Worth
Estimate Recalculated Jun 18, 2025 08:33PM EST
Who is ROCHE HOLDING LTD
ROCHE HOLDING LTD does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Senseonics Holdings, Inc., Allakos Inc., Entrada Therapeutics, Inc., Foundation Medicine, Inc., Jasper Therapeutics, Inc., Pandion Therapeutics Holdco LLC, AILERON THERAPEUTICS INC, Spark Therapeutics, Inc., Aligos Therapeutics, Inc., and BIOVERIS CORP.
SEC CIK
ROCHE HOLDING LTD's CIK is 0000889131
Past Insider Trading and Trends
2007 was ROCHE HOLDING LTD's most active year for acquiring shares with 2 total transactions. ROCHE HOLDING LTD's most active month to acquire stocks was the month of May. 2017 was ROCHE HOLDING LTD's most active year for disposing of shares, totalling 4 transactions. ROCHE HOLDING LTD's most active month to dispose stocks was the month of June. 2017 saw ROCHE HOLDING LTD paying a total of $1,791,000.00 for 698,493 shares, this is the most they've acquired in one year. In 2017 ROCHE HOLDING LTD cashed out on 5,754,448 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
